Avidity Biosciences
RNA
#1876
Rank
โ‚ฌ9.48 B
Marketcap
61,37ย โ‚ฌ
Share price
0.04%
Change (1 day)
88.25%
Change (1 year)

EPS for Avidity Biosciences (RNA)

EPS in 2025 (TTM): -3,71ย โ‚ฌ

According to Avidity Biosciences's latest financial reports the company's current EPS (TTM) is -3,52ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,43ย โ‚ฌ.

EPS history for Avidity Biosciences from 2020 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-3,71ย โ‚ฌ52.51%
2024-2,43ย โ‚ฌ
2022-2,80ย โ‚ฌ-9.02%
2021-3,08ย โ‚ฌ68.93%
2020-1,82ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
1,14ย โ‚ฌ-132.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,17ย โ‚ฌ-190.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-2,31ย โ‚ฌ-34.45%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
8,09ย โ‚ฌ-329.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-1,11ย โ‚ฌ-68.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-42,34ย โ‚ฌ 1,103.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
1,51ย โ‚ฌ-143.06%๐Ÿ‡บ๐Ÿ‡ธ USA